05.06.2023 Views

Oral Screening Report

Oral screening at the 2023 Oncology Conference in London

Oral screening at the 2023 Oncology Conference in London

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Oral</strong> <strong>Screening</strong> <strong>Report</strong><br />

Introduction<br />

Head and neck cancer is a term used to<br />

describe a group of cancers that affect the<br />

throat, sinuses, larynx and mouth and<br />

surrounding areas. <strong>Oral</strong> screening involves an<br />

examination of the neck, mouth and<br />

oropharynx, including the base of the tongue<br />

and soft palate. The dentist checks for<br />

abnormalities including red or white patches,<br />

lumps or unusual growths. If the dentist<br />

observes any of these, they can refer the<br />

patient for biopsies or additional tests.<br />

The Problem<br />

There are currently no formal screening<br />

programmes in the UK for mouth or<br />

oropharyngeal cancers, however, it is<br />

recommended that patients over the age of<br />

18+ visit their dentist at least once a year and<br />

have an oral screening as part of their regular<br />

dental appointment. In the UK, access to<br />

dental care is very poor due to the high cost<br />

and low number of NHS dentists. This means<br />

that there is less opportunity for head and<br />

neck cancers to be detected early and<br />

therefore worsens the prognosis of this<br />

disease.<br />

148<br />

People screened over<br />

two days<br />

Impact Snapshot<br />

2 in 5<br />

People reported having one<br />

of the symptoms of head and<br />

neck cancer<br />

26<br />

People referred for<br />

further investigation<br />

Acknowledgements<br />

Thank you to all of the volunteers who participated in the oral screening and gave permission for their data to be used.<br />

Dentists: Rabab Ahmed, Aikaterina Bopota and Maya Patel<br />

<strong>Report</strong> by Eleanor McFarlane on behalf of The Swallows Head and Neck Cancer Support Group.


<strong>Oral</strong> <strong>Screening</strong> <strong>Report</strong><br />

Methodology<br />

Methodology<br />

148 volunteers were screened across two days at the Oncology Care Conference 2023 in<br />

London using the <strong>Oral</strong>ID device (Forward Science). This device aids visualisation of<br />

abnormalities of the oral mucosal such as cancer and pre-cancer by using fluorescence<br />

technology. The blue light is at a wavelength of 435–460 nm, allowing it to fluoresce green<br />

when shining on healthy tissue. When shining on abnormal tissue, the abnormality appears<br />

dark blue due to to a lack of fluorescent activity. This allows the clinician to observe<br />

abnormalities that may have otherwise been missed.<br />

Symptoms and risk factors for disease<br />

Prior to examination, volunteers were asked to complete a survey to identify their risk of oral<br />

cancers and whether they are experiencing any symptoms. This asked about their demographic<br />

(male or female); lifestyle choices such as whether the patient smoked, drank alcohol, or used<br />

chewing tobacco, Supari or Paan; and whether they experienced any symptoms of head and<br />

neck cancers or had a family history of these diseases. The survey also asked patients to input<br />

when they had last visited their GP and dentist and whether they attend regular visits to these<br />

healthcare professionals.<br />

<strong>Report</strong> of Day 1 Findings<br />

The morning of Day 2 of the conference saw The Swallows CEO, Chris<br />

Curtis, give a presentation entitled '<strong>Oral</strong> screening in the fight against<br />

Head and Neck Cancer'. During this presentation, the statistics from the<br />

Day 1 activities of oral screening were presented and the audience was<br />

encouraged to go and be screened themselves.


Results and Findings<br />

Demographics<br />

Despite the fact that head and neck cancers disproportionately<br />

1<br />

affect males (71% cases male, 29% cases female ), only 18% of<br />

people who volunteered themselves for an oral screening<br />

were male.<br />

Male<br />

18%<br />

Further research into whether this reluctance to come forward<br />

for screenings is observed in dentists and across the general<br />

public is important as it will inform awareness campaigns. The<br />

male demographic should be targeted in campaigns<br />

encouraging people to get oral cancer screenings due to the<br />

disproportionate effects of this disease based on sex.<br />

Female<br />

82%<br />

Symptoms<br />

Prior to the screening, 2 in 5 people reported to be experiencing one of the listed symptoms.<br />

Lump in the<br />

neck<br />

4%<br />

Bleeding (mouth,<br />

nose, ear)<br />

7%<br />

Risk Factors<br />

Paan, Supari and CHewing Tobacco<br />

Just one volunteer said that<br />

they had tried Paan and Supari<br />

(less than 1% of volunteers)<br />

Change in VOice<br />

(hoarseness)<br />

Tooth or Gum<br />

Problems<br />

Ear ache or<br />

sore throat<br />

Sore or Ulcer in<br />

the mouth<br />

Red or white patch in<br />

the mouth<br />

3% 18% 7% 7%<br />

2%<br />

The survey that volunteers took before their screening also asked about their lifestyle habits<br />

and family history of disease which are risk factors for head and neck cancers. 8% of people<br />

said they had a family history of head and neck cancers (including oral cancer).<br />

Answered Yes<br />

Answered No<br />

Ye<br />

Regularly attend a<br />

GP<br />

SMoking Alcohol Regularly attend a<br />

dentist<br />

Despite 70% of people saying they regularly attended a dentist, only 52% of people reported<br />

visiting their dentist in the last year.<br />

1. cancerresearchuk.org


Results and Findings<br />

(continued)<br />

26<br />

These<br />

people were referred to the NHS/dentist/GP for further investigation based on the<br />

results of their screening<br />

all have the potential to be cases of oral cancers. Early diagnosis is crucial<br />

for head and neck cancers, including oral cancers and so oral screening saves<br />

lives.<br />

Case Study 1<br />

On day 2 of the conference, a female<br />

reporting having a lump in her neck and<br />

ulcers in her mouth, volunteered for an oral<br />

screening. Upon examination, the dentists<br />

made an NHS referral for further<br />

investigation. She reported none of the risk<br />

factors for head and neck cancer in the<br />

survey and had last visited her dentist 6<br />

months prior.<br />

Example picture (not actual pateint data)<br />

Dentists' Comments<br />

Lump in the left neck - Post vascular region (non tender & non mobile). Advised referral to<br />

GP for a hospital Ultrasound scan and investigation<br />

Case Study 2<br />

On day 1 of the conference, a female reporting having no symptoms<br />

was found by the dentists to have a traumatic lesion on the left side of<br />

her mouth. When asked, she said that this lesion will not go away and<br />

was therefore referred to her GP for further investigation.<br />

Reflections<br />

In the UK, access to dental services is limited which prevents early recognition<br />

and diagnosis of head and neck cancers, particularly oral cancers. 148 people<br />

participated in a free oral screening service and 26 of those people were referred<br />

for further investigation which could be life saving.<br />

info@theswallows.org.uk<br />

www.theswallows.org.uk

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!